Gold (I)-containing compounds, including aurothioglucose (ATG), are potent
in vitro inhibitors of several selenocysteine-containing enzymes. Gold comp
ounds have also been shown to potentiate the virulence of several viruses i
n mice, including coxsackievirus, implicated asa possible infectious agent
in Keshan disease. One possible mechanism by which gold compounds may be in
creasing the virulence of viral infections in mice is by acting as a seleni
um antagonist in vivo and inducing oxidative stress. To investigate the pos
sible role of gold compounds in inducing oxidative stress in mice, we asses
sed the ability of ATG administered in vivo to inhibit the activity of the
selenocysteine-containing enzymes thioredoxin reductase (Te) and glutathion
e peroxidase (GPX1). Doses as low as 0.025 mg ATG/g body weight caused sign
ificant and prolonged inhibition of TR activity in all tissues examined. No
such inhibition of GPX1 activity was seen, indicating differential in vivo
sensitivity of the enzymes to inhibition by ATG. In liver and heart, some
recovery of TR activity was observed after a 7-d period, but no recovery wa
s observed in pancreas or kidney. Because TR is involved in several importa
nt cellular redox functions, its inhibition most likely will affect multipl
e cellular processes. These results indicate that in vivo administration of
ATG results in significant and long-lasting inhibition of TR activity. Suc
h inhibition of TR could lead to increased levels of oxidative stress in vi
vo, thereby increasing the virulence of several viruses including the coxsa
ckievirus.